The invention relates to a vaccine composition comprising as an active ingredient an effective amount of an isolated S. pneumoniae aspartate carbamoyltransferase catalytic subunit (AC, Accession No. NP_345741), optionally together with one or more pharmaceutically acceptable adjuvant(s).
